Scaling Biomanufacturing: Growth in Single Use Technologies for Biopharmaceuticals Market
Market Overview According to Metastat Insight-style structured analysis, the global single use technologies for biopharmaceuticals market is valued at USD 6,013.9 million in 2024 and is projected to reach USD 10,585.9 million by 2031, exhibiting a CAGR of 11.7% during the forecast period. The market is driven by the demand for cost-effective, flexible manufacturing solutions in biologics production. Single-use bioreactors (SUBs) are revolutionizing the industry by eliminating cleaning and sterilization steps, preventing cross-contamination, and enabling rapid scalability for personalized medicine and complex drug development.
Major Players Profiled in the Market Report: • Avantor • Corning Incorporated • Entegris • Eppendorf SE • Getinge AB • Kühner AG • Lonza • Merck KGaA • New Horizon Biotechnology • Parker Hannifin Corporation • PBS Biotech • Saint-Gobain • Sartorius AG • TECNIC Bioprocess Equipment Manufacturing • Thermo Fisher Scientific
Segments
Bioreactors Leading the Charge By Type, the market is divided into Single-Use Bioreactors (SUBs), Mixing Systems, Storage and Transport Bags, Filtration Systems, Connectors and Tubing, Sampling Systems, and Other Products. Single-Use Bioreactors (SUBs) are a pivotal segment, facilitating efficient cell culture growth without the need for resource-intensive cleaning. Single-Use Mixing Systems and Filtration Systems are also crucial, ensuring homogenous product quality and contaminant removal, respectively.
Monoclonal Antibodies Driving Applications By Application, the market is segmented into Monoclonal Antibody (mAb) Production, Vaccine Manufacturing, Cell and Gene Therapy, Recombinant Protein Production, Blood and Plasma Products, and Other Biopharmaceutical Applications. Monoclonal Antibody Production is a dominant application due to its widespread use in treating cancers and autoimmune disorders. Vaccine Manufacturing and Cell and Gene Therapy are rapidly expanding segments, fueled by global health needs and advancements in genetic medicine.
Manufacturers as Key End-Users By End-User, the market is categorized into Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), and Academic and Research Institutes. Biopharmaceutical Manufacturers represent the largest user base, leveraging single-use tech for efficiency and scalability. CMOs are a fast-growing segment, adopting these technologies to offer flexible, cost-effective services to pharmaceutical clients.
Source: https://www.metastatinsight.com/report/global-single-use-technologies-for-biopharmaceuticals-market
Report Coverage The report offers: • Major growth drivers, restraints, opportunities, and challenges • Comprehensive regional insights • List of key industry players • Key strategies such as technological innovation, product launches, and strategic partnerships • Analysis of trends across all submarkets and application types
Drivers & Restraints
Drivers
Cost Efficiency and Flexibility The elimination of cleaning and sterilization steps significantly reduces operational costs and time. This flexibility allows manufacturers to quickly adapt to changing production demands, a critical advantage for personalized medicine.
Advancements in Biopharmaceuticals The increasing complexity of biologics and the shift towards personalized treatments require agile manufacturing processes. Single-use systems support small-batch production, essential for tailored therapies.
Restraints
Environmental Concerns The substantial volume of plastic waste generated by single-use components raises environmental issues. This concern may push manufacturers to seek more sustainable alternatives or delay full adoption.
High Initial Investment The cost of acquiring specialized single-use equipment and training staff can be prohibitive, particularly for smaller organizations, despite long-term operational savings.
Opportunities
Emerging Markets Growth Developing regions offer significant expansion potential as local biopharmaceutical sectors grow. Increasing demand for biologics worldwide supports the scalability of single-use technologies in these markets.
Regional Insights
North America A dominant market driven by a robust biopharmaceutical industry, advanced healthcare infrastructure, and high adoption of innovative manufacturing technologies in the U.S. and Canada.
Europe Strong growth supported by established pharmaceutical sectors in Germany, the UK, and France, focusing on efficiency and regulatory compliance in drug production.
Asia-Pacific The fastest-growing region, fueled by rapid industrialization in China and India, increasing healthcare investments, and a burgeoning contract manufacturing sector.
South America Brazil and Argentina show potential for growth as local manufacturing capabilities improve and demand for biologics rises.
Middle East & Africa Emerging market with investments in healthcare infrastructure and partnerships aimed at enhancing local drug production capabilities.
Competitive Landscape The market features a mix of global leaders and specialized innovators. Companies are focused on: • Developing advanced SUBs and mixing systems for scalable production • Expanding product portfolios to include sustainable single-use solutions • Forming strategic partnerships to enhance global reach and technological capabilities • Investing in R&D to support complex biologic manufacturing needs • ensuring supply chain reliability for critical components like connectors and tubing
These strategies ensure that key players remain at the forefront of the industry, driving the transition towards more efficient and flexible biopharmaceutical manufacturing globally.
